GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectorite Biomedical Inc (ROCO:4170) » Definitions » Price-to-Operating-Cash-Flow

Vectorite Biomedical (ROCO:4170) Price-to-Operating-Cash-Flow : 548.28 (As of Jun. 06, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Vectorite Biomedical Price-to-Operating-Cash-Flow?

As of today (2024-06-06), Vectorite Biomedical's share price is NT$15.90. Vectorite Biomedical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.03. Hence, Vectorite Biomedical's Price-to-Operating-Cash-Flow Ratio for today is 548.28.

The historical rank and industry rank for Vectorite Biomedical's Price-to-Operating-Cash-Flow or its related term are showing as below:

ROCO:4170' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 25.47   Med: 36.32   Max: 653.33
Current: 548.28

During the past 12 years, Vectorite Biomedical's highest Price-to-Operating-Cash-Flow Ratio was 653.33. The lowest was 25.47. And the median was 36.32.

ROCO:4170's Price-to-Operating-Cash-Flow is ranked worse than
98.97% of 292 companies
in the Biotechnology industry
Industry Median: 25.785 vs ROCO:4170: 548.28

Vectorite Biomedical's Cash Flow from Operations per share for the six months ended in Dec. 2023 was NT$0.08. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.03.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Vectorite Biomedical was -91.10% per year.

During the past 12 years, Vectorite Biomedical's highest 3-Year average Operating Cash Flow per Share Growth Rate was 57.40% per year. The lowest was -74.50% per year. And the median was 3.75% per year.


Vectorite Biomedical Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Vectorite Biomedical's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectorite Biomedical Price-to-Operating-Cash-Flow Chart

Vectorite Biomedical Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 710.00

Vectorite Biomedical Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 710.00

Competitive Comparison of Vectorite Biomedical's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Vectorite Biomedical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vectorite Biomedical's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectorite Biomedical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Vectorite Biomedical's Price-to-Operating-Cash-Flow falls into.



Vectorite Biomedical Price-to-Operating-Cash-Flow Calculation

Vectorite Biomedical's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=15.90/0.029
=548.28

Vectorite Biomedical's Share Price of today is NT$15.90.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vectorite Biomedical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Vectorite Biomedical Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Vectorite Biomedical's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Vectorite Biomedical (ROCO:4170) Business Description

Traded in Other Exchanges
N/A
Address
Xintai 5th Road, 6th Floor, Number 97, Section 1, Yuzhi District, New Taipei City, Taipei, TWN, 22175
Vectorite Biomedical Inc is a Taiwan-based diagnostic and research company. It prepares studies of adult healthy cells, cell preparation and application.

Vectorite Biomedical (ROCO:4170) Headlines

No Headlines